Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028110

CEO and Chairman sold 45,000 shares at an average $35.60 ($1,601,967)

  • CEO and Chairman acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-05-07 Option exercise +45,000 $0.33 $14,850 1,923,180 D
ROBINS CHAD M CEO and Chairman 2020-05-07 Sale −36,186 $35.47 $1,283,517 1,886,994 D
ROBINS CHAD M CEO and Chairman 2020-05-07 Sale −8,814 $36.13 $318,450 1,878,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-05-07 Option exercise · Stock Option (Right to Buy) −45,000 601,560 D
Open-market sales · 45,000 sh · avg $35.60 · $1,601,967
Loading xslF345X03/doc4.xml…